Published in J Cancer Res Clin Oncol on March 23, 2013
Chitinase-3-like-1/YKL-40 as marker of circulating tumor cells. Transl Lung Cancer Res (2015) 0.85
Prognostic significance of E-cadherin expression in hepatocellular carcinoma: a meta-analysis. PLoS One (2014) 0.84
How to target small cell lung cancer. Oncoscience (2015) 0.78
Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver disease. Sci Rep (2016) 0.76
Correlation of Chitinase 3-Like 1 Single Nucleotide Polymorphisms with Hepatocellular Carcinoma in Taiwan. Int J Med Sci (2017) 0.75
Plasma chitinase 3-like 1 is persistently elevated during first month after minimally invasive colorectal cancer resection. World J Gastrointest Oncol (2016) 0.75
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer (2002) 34.99
Hepatocellular carcinoma. Lancet (2012) 18.09
Major causes of death among men and women in China. N Engl J Med (2005) 11.80
Biomarkers for epithelial-mesenchymal transitions. J Clin Invest (2009) 8.76
Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways. Oncogene (2005) 5.50
Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Hepatology (2009) 3.42
Hepatocellular carcinoma: the need for progress. J Clin Oncol (2005) 3.11
Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol (1993) 2.74
Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma. Clin Cancer Res (2006) 1.91
Role of glycogen synthase kinase-3 in cell fate and epithelial-mesenchymal transitions. Cells Tissues Organs (2007) 1.77
Evolution of mammalian chitinase(-like) members of family 18 glycosyl hydrolases. Genetics (2007) 1.73
Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection. J Hepatol (2007) 1.71
Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray. J Cancer Res Clin Oncol (2002) 1.69
Metastasis and AKT activation. Cell Cycle (2008) 1.68
Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells. Exp Cell Res (1999) 1.66
Identification of proteins secreted by human osteoblastic cells in culture. J Bone Miner Res (1992) 1.60
Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastoma. J Biol Chem (2011) 1.50
High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival. Breast Cancer Res Treat (2003) 1.21
Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis in colorectal cancer. Oncogene (2011) 1.19
Activation of Akt-mTOR-p70S6K pathway in angiogenesis in hepatocellular carcinoma. Oncol Rep (2008) 1.16
Emergence of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin axis in transforming growth factor-β-induced epithelial-mesenchymal transition. Cells Tissues Organs (2010) 1.11
CHI3L1 (YKL-40) is expressed in human gliomas and regulates the invasion, growth and survival of glioma cells. Int J Cancer (2011) 1.07
Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer. Cancer (2010) 0.99
Prognostic implications of immunohistochemically detected YKL-40 expression in breast cancer. World J Surg Oncol (2007) 0.98
Overexpression of YKL-40 is an independent prognostic marker in gastric cancer. Hum Pathol (2009) 0.97
Breast cancer expression of YKL-40 correlates with tumour grade, poor differentiation, and other cancer markers. Br J Cancer (2011) 0.93
YKL-40 as a marker of joint involvement in inflammatory bowel disease. Clin Chem (2003) 0.88
Inhibitory activity of YKL-40 in mammary epithelial cell differentiation and polarization induced by lactogenic hormones: a role in mammary tissue involution. PLoS One (2011) 0.87
YKL-40 expression in human hepatocellular carcinoma: a potential biomarker? Hepatobiliary Pancreat Dis Int (2011) 0.86
Serum YKL-40 as a marker of disease activity and stricture formation in patients with Crohn's disease. J Gastroenterol Hepatol (2007) 0.86
Expression of pERK and pAKT in pediatric high grade astrocytomas: correlation with YKL40 and prognostic significance. Neuropathology (2011) 0.86
Association between YKL-40 and adult primary astrocytoma. Cancer (2010) 0.86
YKL-40 is elevated in patients with peripheral arterial disease and diabetes or pre-diabetes. Atherosclerosis (2012) 0.86
High serum YKL-40 is a poor prognostic marker in patients with advanced non-small cell lung cancer. Acta Oncol (2010) 0.83
Multiple mechanisms confining RNA polymerase II ubiquitylation to polymerases undergoing transcriptional arrest. Cell (2005) 1.93
Simple sequence repeat-based consensus linkage map of Bombyx mori. Proc Natl Acad Sci U S A (2005) 1.35
Major and minor QTL and epistasis contribute to fatty acid compositions and oil concentration in high-oil maize. Theor Appl Genet (2009) 1.26
Prognostic significance of osteopontin in hepatocellular carcinoma: a meta-analysis. Int J Cancer (2011) 1.19
P48 is a predictive marker for outcome of postoperative interferon-alpha treatment in patients with hepatitis B virus infection-related hepatocellular carcinoma. Cancer (2006) 1.11
A rat model for stable chronic obstructive pulmonary disease induced by cigarette smoke inhalation and repetitive bacterial infection. Biol Pharm Bull (2012) 1.07
High-level expression of periostin is closely related to metastatic potential and poor prognosis of hepatocellular carcinoma. Med Oncol (2012) 1.06
Effects of interferon treatment on development and progression of hepatocellular carcinoma in patients with chronic virus infection: a meta-analysis of randomized controlled trials. Int J Cancer (2011) 0.99
Ligation of TLR2 by versican: a link between inflammation and metastasis. Arch Med Res (2009) 0.95
Extracellular matrix protein 1, a novel prognostic factor, is associated with metastatic potential of hepatocellular carcinoma. Med Oncol (2010) 0.95
Protein phosphatase-1 modulates the function of Pax-6, a transcription factor controlling brain and eye development. J Biol Chem (2007) 0.95
Repeated and controlled growth of monolayer, bilayer and few-layer hexagonal boron nitride on Pt foils. ACS Nano (2013) 0.94
Dietary carbohydrate/lipid ratios affect stress, oxidative status and non-specific immune responses of fingerling blunt snout bream, Megalobrama amblycephala. Fish Shellfish Immunol (2012) 0.92
Pharmacophore, QSAR, and binding mode studies of substrates of human cytochrome P450 2D6 (CYP2D6) using molecular docking and virtual mutations and an application to chinese herbal medicine screening. Curr Pharm Biotechnol (2012) 0.92
Activation of STAT3 signal pathway correlates with twist and E-cadherin expression in hepatocellular carcinoma and their clinical significance. J Surg Res (2010) 0.90
Docosahexaenoic acid (DHA) induces apoptosis in human hepatocellular carcinoma cells. Int J Clin Exp Pathol (2013) 0.90
Antitumoral activity of rapamycin mediated through inhibition of HIF-1alpha and VEGF in hepatocellular carcinoma. Dig Dis Sci (2008) 0.89
Estrogen suppresses metastasis in rat hepatocellular carcinoma through decreasing interleukin-6 and hepatocyte growth factor expression. Inflammation (2012) 0.89
Overexpression of Mortalin in hepatocellular carcinoma and its relationship with angiogenesis and epithelial to mesenchymal transition. Int J Oncol (2013) 0.89
Diagnostic and prognostic significance of serum miR-24-3p in HBV-related hepatocellular carcinoma. Med Oncol (2014) 0.88
Developmental expression of three small GTPases in the mouse eye. Mol Vis (2007) 0.88
Ischemic postconditioning during reperfusion attenuates intestinal injury and mucosal cell apoptosis by inhibiting JAK/STAT signaling activation. Shock (2012) 0.88
Effects of interferon alpha treatment on recurrence and survival after complete resection or ablation of hepatocellular carcinoma: a meta-analysis of randomized controlled trials. Int J Cancer (2009) 0.87
Gene cloning and heterologous expression of a novel endoglucanase, swollenin, from Trichoderma pseudokoningii S38. Biosci Biotechnol Biochem (2008) 0.87
Combined effects of dietary fructooligosaccharide and Bacillus licheniformis on innate immunity, antioxidant capability and disease resistance of triangular bream (Megalobrama terminalis). Fish Shellfish Immunol (2013) 0.86
Nucleotide diversity and molecular evolution of the PSY1 gene in Zea mays compared to some other grass species. Theor Appl Genet (2009) 0.86
Diagnostic and prognostic significance of peroxiredoxin 1 expression in human hepatocellular carcinoma. Med Oncol (2013) 0.85
[Effects of Bufei Jianpi Recipe on the diaphragmatic neural discharge and the diaphragmatic muscle function in rats with chronic obstructive pulmonary disease]. Zhongguo Zhong Xi Yi Jie He Za Zhi (2012) 0.85
Octreotide acts as an antitumor angiogenesis compound and suppresses tumor growth in nude mice bearing human hepatocellular carcinoma xenografts. J Cancer Res Clin Oncol (2003) 0.85
A nonradioactive assay for poly(a)-specific ribonuclease activity by methylene blue colorimetry. Protein Pept Lett (2006) 0.84
Screening and identification of proteins interacting with nucleostemin. World J Gastroenterol (2005) 0.84
Role of the RRM domain in the activity, structure and stability of poly(A)-specific ribonuclease. Arch Biochem Biophys (2007) 0.84
Association of mitochondrial dysfunction with oxidative stress and immune suppression in Blunt Snout Bream Megalobrama amblycephala fed a high-fat diet. J Aquat Anim Health (2014) 0.83
Conformational stability and multistate unfolding of poly(A)-specific ribonuclease. FEBS J (2009) 0.83
Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinoma. Clin Cancer Res (2007) 0.83
Targeted killing effects of double CD and TK suicide genes controlled by survivin promoter on gastric cancer cell. Mol Biol Rep (2010) 0.83
Inhibitory effect of S-adenosylmethionine on the growth of human gastric cancer cells in vivo and in vitro. Chin J Cancer (2010) 0.83
Trichlorfon-induced apoptosis in hepatocyte primary cultures of Carassius auratus gibelio. Chemosphere (2009) 0.83
Overexpression of HOXA13 as a potential marker for diagnosis and poor prognosis of hepatocellular carcinoma. Tohoku J Exp Med (2014) 0.82
Contrast expression patterns of JNK1 during sex reversal of the rice-field eel. J Exp Zool B Mol Dev Evol (2010) 0.82
Overexpression of cyclooxygenase-2 in noncancerous liver tissue increases the postoperative recurrence of hepatocellular carcinoma in patients with hepatitis B virus-related cirrhosis. Can J Gastroenterol (2010) 0.82
Blockage of transforming growth factor beta receptors prevents progression of pig serum-induced rat liver fibrosis. World J Gastroenterol (2004) 0.82
Knockdown of Akt1 promotes Akt2 upregulation and resistance to oxidative-stress-induced apoptosis through control of multiple signaling pathways. Antioxid Redox Signal (2011) 0.82
Human telomerase reverse transcriptase immortalizes bovine lens epithelial cells and suppresses differentiation through regulation of the ERK signaling pathway. J Biol Chem (2005) 0.82
[Thinking on the junction point of Chinese medicine in comparative effectiveness research on chronic obstructive pulmonary disease]. Zhongguo Zhong Xi Yi Jie He Za Zhi (2014) 0.81
Effectiveness of Bufei Yishen Granule combined with acupoint sticking therapy on quality of life in patients with stable chronic obstructive pulmonary disease. Chin J Integr Med (2013) 0.81
Interferon: a sharp sword to overcome HCV or HBV-related liver diseases? Hepat Mon (2010) 0.81
Periostin: a putative mediator involved in tumour resistance to anti-angiogenic therapy? Cell Biol Int (2011) 0.81
Ligand- and protein-based modeling studies of the inhibitors of human cytochrome P450 2D6 and a virtual screening for potential inhibitors from the Chinese herbal medicine, Scutellaria baicalensis (Huangqin,Baikal Skullcap). Comb Chem High Throughput Screen (2012) 0.81
Multistate folding of a hyperthermostable Fe-superoxide dismutase (TcSOD) in guanidinium hydrochloride: The importance of the quaternary structure. Biochim Biophys Acta (2007) 0.81
Two distinct states of Escherichia coli cells that overexpress recombinant heterogeneous β-galactosidase. J Biol Chem (2012) 0.80
STAT3 activation mediates epithelial-to-mesenchymal transition in human hepatocellular carcinoma cells. Hepatogastroenterology (2014) 0.80
[Human stool vimentin, oncostatin M receptor and tissue factor pathway inhibitor 2 gene methylation analysis for the detection of colorectal neoplasms]. Zhonghua Yi Xue Za Zhi (2011) 0.80
Beneficial effects of S-adenosyl-L-methionine on post-hepatectomy residual liver function: a prospective, randomized, controlled clinical trial. Hepatogastroenterology (2013) 0.80
Expression of ornithine decarboxylase in precancerous and cancerous gastric lesions. World J Gastroenterol (2007) 0.80
CPT-11 Chemotherapy Rescued A Patient with Atypical Sclerosing Epithelioid Fibrosarcoma from Emergent Condition. Chin J Cancer Res (2012) 0.80